Articles

Impact of promoter polymorphisms in key regulators of the intrinsic apoptosis pathway on the outcome of childhood acute lymphoblastic leukemia

Division of Hematology-Oncology, Research Center, CHU Sainte-Justine, Montreal, Canada
Division of Hematology-Oncology, Research Center, CHU Sainte-Justine, Montreal, Canada
Division of Hematology-Oncology, Research Center, CHU Sainte-Justine, Montreal, Canada
Division of Hematology-Oncology, Research Center, CHU Sainte-Justine, Montreal, Canada
Division of Hematology-Oncology, Research Center, CHU Sainte-Justine, Montreal, Canada
Division of Hematology-Oncology, Research Center, CHU Sainte-Justine, Montreal, Canada
Division of Hematology-Oncology, Research Center, CHU Sainte-Justine, Montreal, Canada;Department of Pediatrics, Faculty of Medicine, Université de Montréal, Canada
Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA;Division of Hematology/Oncology, Children’s Hospital, Boston, MA, USA
Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA;Division of Hematology/Oncology, Children’s Hospital, Boston, MA, USA
Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA
Department of Pathology, Brigham and Women’s Hospital, Boston, MA, USA
Division of Hematology-Oncology, Research Center, CHU Sainte-Justine, Montreal, Canada
Division of Hematology-Oncology, Research Center, CHU Sainte-Justine, Montreal, Canada;Department of Pediatrics, Faculty of Medicine, Université de Montréal, Canada
Division of Hematology-Oncology, Research Center, CHU Sainte-Justine, Montreal, Canada;Department of Pediatrics, Faculty of Medicine, Université de Montréal, Canada
Vol. 99 No. 2 (2014): February, 2014 https://doi.org/10.3324/haematol.2013.085340